Riskpilot← Back to searchSign inGet full accessNUTRAQ AS
ASActiveOrg 893905952Sjølyst Plass 3, 0278 OsloWholesale of other food · NACE 4638Est. 200967 employees
Revenue 2024
NOK 474,3M
+11% vs 2023
EBITDA margin
17.8%
+31% vs 2023
Equity ratio
22.8%
Financial strength
Net profit 2024
NOK 136,5M
+194% vs 2023
| Revenue | NOK 474,3M | +11% |
| EBITDA | NOK 84,6M | +31% |
| Net profit | NOK 136,5M | +194% |
| Total assets | NOK 434,4M | -1% |
| Equity | NOK 99M | +28% |
| Employees | 67 | — |
Legal name
NUTRAQ AS
Org number
893905952
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
1. april 2009
Share capital
NOK 2 500 000
Employees
67 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
På saklig og vitenskaplig grunnlag å importere, eksportere, produsere og selge ingredienser og produkter til bedriftskunder innen farmasøytisk industri, helsekost, hudpleie og tilsvarende markeder samt virksomhet som står i forbindelse med dette, herunder deltagelse i andre selskap med lignende virksomhet.
Address
Sjølyst Plass 3, 0278 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 85 571 | 86 537 | 0 | 0 | 145 419 | 209 504 | 209 325 | 186 121 | 189 791 | 208 084 | 276 237 | 349 912 | 382 049 | 428 475 | 474 326 |
| Staff expenses | −5 429 | −3 010 | −0 | −0 | −12 586 | −32 972 | −39 918 | −42 649 | −43 798 | −41 201 | −48 848 | −69 073 | −74 182 | −92 695 | −96 974 |
| EBITDA | 32 389 | −5 290 | 0 | 0 | 28 399 | 39 853 | 51 047 | 30 470 | 31 900 | 34 750 | 39 187 | 55 611 | 81 904 | 64 506 | 84 558 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −2 535 | −2 577 | −10 045 | −9 591 | −4 161 | −1 351 | −4 243 | −6 864 | −12 333 | −11 416 | −14 225 |
| EBIT | 32 389 | −5 290 | 0 | 0 | 25 863 | 37 276 | 41 002 | 20 879 | 27 739 | 33 400 | 34 944 | 48 746 | 69 571 | 53 090 | 70 333 |
| Net financials | 0 | 495 | 0 | 0 | −10 183 | −12 124 | −3 926 | 49 009 | 35 946 | 16 507 | 18 125 | 17 559 | 182 890 | 2 922 | 79 476 |
| Profit before tax | 32 389 | −4 795 | 0 | 0 | 15 680 | 25 152 | 37 076 | 69 888 | 63 685 | 49 907 | 53 069 | 66 305 | 252 461 | 56 013 | 149 809 |
| Tax | 9 084 | −1 281 | −0 | −0 | 8 232 | 7 113 | 9 283 | 4 812 | 6 475 | 7 430 | 7 502 | 11 243 | 14 885 | 9 527 | 13 305 |
| Net profit | 23 305 | −3 514 | 0 | 0 | 7 449 | 18 039 | 27 792 | 65 076 | 57 210 | 42 477 | 45 568 | 55 063 | 237 576 | 46 486 | 136 504 |
| Item | 2009 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 60 698 | 41 387 | — | — | 198 823 | 290 681 | 230 484 | 149 531 | 243 767 | 205 064 | 350 815 | 261 614 | 368 808 | 437 439 | 434 366 |
| Equity | 24 837 | 9 323 | — | — | 40 165 | 107 896 | 29 620 | 20 877 | 15 795 | 44 507 | 43 016 | 59 079 | 200 695 | 77 588 | 99 006 |
| Long-term debt | 0 | 0 | 0 | 0 | 7 666 | 51 255 | 173 | 1 051 | 654 | 328 | 164 | 112 520 | 72 376 | 260 404 | 229 508 |
| Short-term debt | 35 861 | 32 064 | 0 | 0 | 150 991 | 131 529 | 200 691 | 127 604 | 227 317 | 160 230 | 307 636 | 90 015 | 95 737 | 99 448 | 105 852 |
| Total debt | 35 861 | 32 064 | 0 | 0 | 158 657 | 182 784 | 200 863 | 128 655 | 227 972 | 160 557 | 307 800 | 202 536 | 168 113 | 359 852 | 335 360 |
EBITDA margin
17.8%
This company
15.8%
Market median
+13% vs market
20092024
Equity ratio
22.8%
This company
38.2%
Market median
-40% vs market
20092024
Return on equity
137.9%
This company
18.4%
Market median
+649% vs market
20092024
Net profit margin
28.8%
This company
8.1%
Market median
+256% vs market
20092024
Asset turnover
1.09×
This company
1.12×
Market median
+3% vs market
20092024
Debt / equity
3.39×
This company
0.62×
Market median
-447% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JS Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
CN Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Orkla Health Holding As | Company | 100.0% | 100.0% | 2024 |
Orkla Health As | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Orkla Asa
NUTRAQ AS Board members of NUTRAQ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Sebastian Schmidt Slørdahl | Chief Executive Officer | 0 companies |
| Cecilie Nordstrøm | Chief Executive Officer | 0 companies |
| Christian Rykke | Chairman | 0 companies |
| Karolina Grønås Henriksen | Board of Directors | 0 companies |
| Marius Fladvad Størdal | Board of Directors | 0 companies |
| Hege Holter Brekke | Chairman | 0 companies |
| Rasmus Emil Andersen | Board of Directors | 0 companies |
| Shaher Yar Khan | Board of Directors | 0 companies |
| Camilla Tellefsdal Robstad | Board of Directors | 0 companies |
| Isabelle Valerie Ghislaine Ducellier | Chairman | 0 companies |
| Gustaf Solerød Christensen | Board of Directors | 0 companies |
| Øyvind Andreas Torpp | Chairman | 0 companies |
| Sara Johanna Sundén | Board of Directors | 0 companies |
| Are Nakkim | Board of Directors | 0 companies |
| Andres Kongsgaard Flaaten | Board of Directors | 0 companies |